Studies with preclinical glioma models demonstrated that increased concentrations of glutamate can lead to downregulation of KCC2, leading to GABAergic disinhibition in the peritumoral cortex; this mechanism may contribute to glioma-associated epileptogenesis in humans [63,64]. Here, SLC12A5 is linked to central nervous system cancer.